Sullivan Christopher Ryan sold AVTX
August 18, 2026 · Form 4 insider transaction
Sullivan Christopher Ryan sold 31,031 shares of Avalo Therapeutics, Inc. at $20.05 per share, a transaction worth $622.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
31,031
Price
$20.05
Total value
$622.3K
InsiderSullivan Christopher Ryan
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 18, 2026
Filing dateAugust 19, 2026
Shares owned after39,900
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported securities were sold in multiple transactions at prices ranging from $20.00 to $20.265. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.